as on February 6, 2026 at 9:31 pm IST
Day's Low
Day's High
3.60%
Downside
0.28%
Upside
52 Week's Low
52 Week's High
41.35%
Downside
4.61%
Upside
as on February 6, 2026 at 4:01 pm IST
Market Cap
₹28,733.51 Cr
Return on Equity (ROE)
12.79
PE Ratio (TTM)
33.02
Return on capital employed (ROCE)
14.36
Industry PE ratio
40.88
Beta (LTM)
1.04
P/B Ratio
6.72
Dividend Yield
0.28
PEG Ratio
2.49
Quarterly Earnings Growth YOY
48.23
EPS (TTM)
37.34
Sector
Pharmaceuticals
Book Value
234.65
as on February 6, 2026 at 4:01 pm IST
Emcure Pharma in the last 5 years
Lowest (24.97x)
April 9, 2025
Today (33.02x)
February 6, 2026
Industry (40.88x)
February 6, 2026
Highest (53.98x)
September 18, 2024
Today’s Price to Earnings Ratio: 33.02x
Compare market cap, revenue, PE, and other key metrics of Emcure Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 28,733.51 | 2.3% | 0.63 | 707 | 7,896 | |
| NA | 78.02 | 42.42% | 0.70 | 1 | 45 | |
| NA | 981.74 | 62.11% | 0.50 | 45 | 647 | |
| NA | 12.44 | 1.49% | 0.00 | -3 | 28 | |
| BUY | 7,962.80 | 0.61% | 0.72 | 3,597 | 4,565 |
Based on 6 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Emcure Pharma . Average target price of ₹1681.83
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Emcure Pharma .
What analysts predicted
10.96%UPSIDE
Target Price
₹1681.83
Current Price
₹1515.7
Analyzed by
6 Analysts
High
₹1750
Target
₹1681.83
Low
₹1550
Emcure Pharma target price ₹1681.83, a slight upside of 10.96% compared to current price of ₹1515.7. According to 6 analysts rating.
Source: S&P Global Market Intelligence
Search interest for Emcure Pharmaceuticals Ltd Stock has increased by 85% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:85% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Emcure Pharma .
Emcure Pharmaceuticals Ltd’s net profit jumped 49.97% since last year same period to ₹230.54Cr in the Q3 2025-2026. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated -5.31% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Emcure Pharmaceuticals Ltd has declared dividend of ₹3.00 per share on 22 May 2025 - translating a dividend yield of 0.20%.
Read More about DividendsCheck stock indices that include Emcure Pharma .
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, EMCURE stock has moved up by 11.3%
MF Holding Up
![]()
Mutual Funds have increased holdings from 3.58% to 4.83% in Dec 2025 quarter
FII Holding Up
![]()
Foreign Institutions have increased holdings from 3.29% to 3.59% in Dec 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 14.46% to 12.44% in Dec 2025 quarter
Promoter Holding Down
![]()
Promoters have decreased holdings from 77.88% to 77.87% in Dec 2025 quarter
| Organisation | Emcure Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Emcure Pharma share price today stands at ₹1515.7 as on at the close of the market. Emcure Pharma share today touched a day high of ₹1520 and a low of ₹1461.1.
Emcure Pharma touched a 52 week high of ₹1585.6 and a 52 week low of ₹889. Emcure Pharma share price today i.e. is closed at ₹1515.7, which is -4.41% down from its 52 week high and 70.49% up from its 52 week low.
Emcure Pharma market capitalisation is ₹28,733.51 Cr as on .
To buy Emcure Pharma shares, you need to follow these steps:
Emcure Pharma trading volume is 94.19K as on . This means that 94.19K shares of Emcure Pharma were bought and sold on the stock market during today's trading session.